Oxurion NV (GB:0G99) has released an update.
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
Oxurion NV, a biopharmaceutical company, has announced that its Extraordinary General Meeting on July 4, 2024, failed to reach the legally required quorum, leading to the adjournment without any resolutions. Consequently, the company has scheduled a new EGM for July 24, 2024, to discuss the proposed reverse stock split, with the decision-making process adjusted to proceed regardless of the quorum.
For further insights into GB:0G99 stock, check out TipRanks’ Stock Analysis page.
